Patients suffering dilated chagasic cardiopathy or non chagasic cardiopathy show an increased levels of tumor necrosis factor α;Pacientes con cardiomiopatía dilatada chagásica y cardiopatía no chagásica presentan niveles elevados del factor de necrosis tumoral α

Investigacion Clinica

Volumn 46, Issue 3, 2005, Pages 229-240

  D'Angelo Mendoza, Elisa ^a   Rodríguez Bonfante, Claudina ^a   Camacho, Ignacio ^a   Martínez, Johana ^a   Perdomo, Tania ^a   Cabrera, Alejandro ^b   Bonfante Cabarcas, Rafael ^a  

^a UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

^b Hospital Baudilio Lara   (Venezuela)

Author keywords

Chagas' disease; Chagasic cardiopathy; Cytokines; Dilated cardiopathy; TNF ; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOMYOPATHY; CHAGAS DISEASE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMMUNOPATHOGENESIS; MALE; PREDICTION; RISK FACTOR; SUDDEN DEATH; WORK DISABILITY;

ADULT; AGED; CARDIOMYOPATHIES; CHAGAS CARDIOMYOPATHY; HUMANS; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT;

EID: 24644442805     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Moncayo A. Chagas' disease. En: World Health Organization. Tropical disease research, progress 1991-92. Geneva: WHO. 1993; 67-75.
2. Moncayo A. Chagas' disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the southern cone countries. Mem Inst. Oswaldo Cruz. 2003; 98: 577-591.
3. OPS/OMS.http://www.ops-oms.org.Ve/ site/venezuela/ven-sit-salud-nuevo. htm. 2002.
4. Fuenmayor AJ, Fuenmayor AM, Carrasco H, Parada H, Fuenmayor C y Jugo D. Results of electrophysiologic studies in patients with acute Chagasic myocarditis. Clin Cardiol 1997; 20: 1021-1024.
5. Parada H, Carrasco HA, Añez N, Fuenmayor C, Inglessis I. Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study. Int J Cardiol 1997; 60:49-54.
6. Añez N, Carrasco H, Parada H, Crisante G, Rojas A, Gonzalez N, Ramírez JL, Guevara P, Rivero C, Borges R, Scorza JV. Acute Chagas' disease in western Venezuela: a clinical, seroparasitologic and epidemiologic study. Am J Trop Med Hyg 1999; 60:215-222.
7. De Oliveira Macedo V. Forma Indeterminada da Doença de Chagas. En Pinto Días JC y Rodríguez Coura J. Eds. Clínica y Terapeútica da Doença de Chagas. Rio de Janeiro Editorial Fiocruz. 1997; p:135-151.
8. Brener Z, Gazzinelli R. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Inmunol 1997; 114: 103-110.
9. Rassi A, Tranchesi J, Tranchesi B. Doença de Chagas. En Veronesi A. Eds. Doenças Infecciosas Parasitarias. Río de Janeiro, Guanabara Koogan. 1991; p. 674-705.
10. Costa G. Cardiopatía Crónica: Insuficiencia Cardíaca. En Pinto Dias, J.G. y Rodríguez Coura, J. Eds. Clínica y Terapeútica da Doenca de Chagas. Rio de Janeiro, Editorial Fiocruz. 1997; p: 223-236.
11. Bestetti RB, Coutinho-Netto J, Staibano L, Pinto LZ, Muccillo G, Oliveira JS. Peripheral and coronary sinus catecholamine levels in patients with severe congestive heart failure due to Chagas' disease. Cardiology 1995; 86: 202-206.
12. Milei J, Stornino R, Jorg M, Chiale P, Schetjman D, Sterin-Borda L, Borda E, Denduchis B. Patogenia. En Storino R y Milei J. Eds. Enfermedad de Chagas. Buenos Aires. Editorial Doyma Argentina S.A. 1994; p:103-128.
13. Gulick TS, Chung MK, Pieper SJ, Lange LG, Schreiner GF. Interleukin 1 and tumor necrosis factor inhibit cardiac myocite beta adrenergic responsiveness. Proc Natl Acad Sci USA 1989; 86: 6753-6757.
14. Chung MK, Gulick TS, Rotondo RE, Schreiner GF, Lange LG. Mechanism of cytokine inhibition of β-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. Circ Res 1990; 67:753-763.
15. Blum A, Miller H: Role of cytokines in heart failure. Am Heart J 1998; 135:181-186.
16. Dutra WO, Gollob KJ, Pinto-Días JG, Gazzinelli G, Correa-Oliveira R, Coffman RL, Carvalho-Parra JF. Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi infection. Scand J Immunol 1997; 45:74-80.
17. Ward LS, Guariento ME, Fernandes GA, Maciel RM. Serum cytokines in chronic Chagas' disease. Rev Soc Bras Med Trop 1999; 32:285-289.
18. Perez-Fuentes R, Guegan JF, Barnabe G, Lopez-Colombo A, Salgado-Rosas H, Torres-Rasgado E, Briones B, Romero-Diaz M, Ramos-Jimenez J, Sanchez-Guillén M del C. Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals. Int J Parasitol 2003; 33:293-299.
19. Ferreira RC, Ianni BM, Abel LC, Buck P, Mady C, Kalil J, Cunha-Neto E. Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/ "indeterminate" and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz 2003; 98:407-411.
20. Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis 2004; 38: 943-950.
21. Añez N, Gonzalez N, Crisante G, Rojas A, Premoli G, Ramirez JL, Guevara P y Chiurillo MA. Curso Taller: Pruebas confirmatorias en el diagnóstico de la enfermedad de Chagas. XVIII Jornadas "José Witremundo Torrealba". 1999; San Carlos, Venezuela.
22. Carrasco HA, Parada H, Guerrero L, Duque M, Duran D, Molina C. Prognostic implications of clinical, electrocardiographic and hemodynamic findings in chronic Chagas' disease. Int J Cardiol 1994; 43:27-38.
23. Reis DD, Jones EM, Tostes Jr S, Lopes ER, Gazzinelli G, Colley DG, McCurley TL Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-α+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg 1993; 48: 637-644.
24. Souza PE, Rocha MO, Rocha-Vieira E, Menezes CA, Chaves AC, Gollob KJ, Dutra WO. Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect Immun 2004; 72:5283-5291.
25. Menezes CA, Rocha MO, Souza PE, Chaves AC, Gollob KJ, Dutra WO. Phenotypic and functional characteristics of CD28+ and CD28- cells from chagasic patients: distinct repertoire and cytokine expression. Clin Exp Immunol 2004; 137:129-138.
26. Cunha-Neto E, Rizzo LV, Albuquerque F, Abel L, Guilherme L, Bocchi E, Bacal F, Carrara D, Ianni B, Mady C, Kalil J. Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. Braz J Med Biol Res 1998; 31:133-137.
27. Sharma R, Al-Nasser FO, Anker SD. The importance of tumor necrosis factor and lipoproteins in the pathogenesis of chronic heart failure. Heart Fail Monit 2001; 2: 42-47.
28. Derouich-Guergour D, Brenier-Pinchart MP, Ambroise-Thomas P, Pelloux H. Tumour necrosis factor alpha receptors: role in the physiopathology of protozoan parasite infections. Int J Parasitol 2001; 31: 763-769.
29. Aggarwal BB, Natarajan K. Tumor necrosis factor: developments during the last decade. Eur Cytokyne Netw 1996; 7: 93-124.
30. Chen G, Goedel DV. TNF-R1 signaling: a beautiful pathway. Science 2002; 296:1634-1635.
31. Laucella SA, Rottenberg ME, De Titto EH. Role of cytokines in resistance and pathology in Trypanosoma cruzi infection. Rev Argent Microbiol 1996; 28:99-109.
32. Muller-Werdan U, Engelmann H, Werdan K. Cardiodepression by tumor necrosis factor-alpha. Eur Cytokine Netw 1998; 9:689-691.
33. Mady C, Cardoso RH, Barretto AC, da LP, Bellotti G, Pileggi F. Survival and predictors of survival in patients with congestive heart failure due to Chagas cardiomyopathy. Circulation 1994; 90:3098-3102.
34. Palacios-Pru E, Carrasco H, Scorza C, Espinoza R. Ultrastructural characteristics of different stages of human chagasic myocarditis. Am J Trop Med Hyg 1989; 41:29-40.
35. Andrade ZA. Immunopathology Chagas' disease. Mem. Inst Oswaldo Cruz 1999; 94: 71-80.
36. Geiger SM, Massara CL, Bethony J, Soboslay PT, Carvalho OS, Correa-Oliveira R. Cellular responses and cytokine profiles in Ascaris lumbricoides and Trichuris trichiura infected patients. Parasite Immunol 2002; 24:499-509.
37. Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, Camm AJ, Northfield TC. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997 Sep; 78(3):273-277.
38. Barbosa Jr AA, Andrade ZA. Identificação do Trypanososoma cruzi nos tecidos extracardíacos de portadores de miocardite crônica chagásica. Rev Soc Bras Med Trop 1984; 17:123-126.
39. Novoa-Montero, D. ¿Cardiopatía crónica endémica rural chagásica, o crónica común en chagásicos y no chagásicos? (Conclusiones de veinte años de investigaciones epidemiológicas y clínico-cardiológicas en Venezuela). Rev Soc Ven Microbiol 2002; 22:88-98.
40. Salones O, Santoya L, Sibulo C, Suárez S, Terán L, Jara A, Rodríguez-Bonfante G, Arrieche S. Estudio electrocardiográfico de individuos seropositivos y seronegativos para Trypanosoma cruzi de la comunidad de arenales, municipio Torres, estado Lara. Acta Cient Venez 2004; 55 (Sup.1):145.
41. Cihakova D, Sharma RB, Fairweather D, Afanasyeva M, Rose NR. Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol Med 2004; 102:175-194.
42. Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY, McTiernan C. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 2000; 35:537-544.